Polaris Pharmaceuticals-KY Announces Re-election of Chairman
Polaris Pharmaceuticals-KY (stock code 6550) announced on May 15, 2026, that its Board of Directors has re-elected Chen Xian-Zhe as Chairman. The re-election is a result of the expiration of his previous term. The company stated that this event is considered to have a significant impact on shareholder equity or stock prices.
📋 Article Processing Timeline
- 📰 Published: May 16, 2026 at 12:57
- 🔍 Collected: May 16, 2026 at 12:57 (0 min after Published)
- 🤖 AI Analyzed: May 16, 2026 at 14:45 (1h 48m after Collected)
Announcement Date: 1150516
Spokesperson Date: 1150515
Spokesperson Time: 211614
Company Code: 6550
Company Name: Polaris Pharmaceuticals-KY
Subject: Announcement of the election of the Chairman by the company's Board of Directors
Compliance Clause: Clause 6
Date of Fact Occurrence: 1150515
Description:
1. Date of Board Resolution or Change: 115/05/15
2. Personnel Type (Please enter Chairman or General Manager): Chairman
3. Former Incumbent's Name: Chen Xian-Zhe
4. Former Incumbent's Brief: Chairman of Polaris Pharmaceuticals Group Co., Ltd.
5. New Incumbent's Name: Chen Xian-Zhe
6. New Incumbent's Brief: Chairman of Polaris Pharmaceuticals Group Co., Ltd.
7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Job Adjustment', 'Redundancy', 'Retirement', 'Death', or 'New Appointment'): Term Expiration
8. Reason for Change: Re-election due to term expiration
9. Effective Date of New Appointment: 115/05/15
10. Other Matters Requiring Notification (If the subject of the event or resolution is a publicly issued company or above, this major information also complies with Article 7, Clause 6 of the Enforcement Rules of the Securities Transaction Act regarding matters that have a significant impact on shareholder equity or stock prices): None
Spokesperson Date: 1150515
Spokesperson Time: 211614
Company Code: 6550
Company Name: Polaris Pharmaceuticals-KY
Subject: Announcement of the election of the Chairman by the company's Board of Directors
Compliance Clause: Clause 6
Date of Fact Occurrence: 1150515
Description:
1. Date of Board Resolution or Change: 115/05/15
2. Personnel Type (Please enter Chairman or General Manager): Chairman
3. Former Incumbent's Name: Chen Xian-Zhe
4. Former Incumbent's Brief: Chairman of Polaris Pharmaceuticals Group Co., Ltd.
5. New Incumbent's Name: Chen Xian-Zhe
6. New Incumbent's Brief: Chairman of Polaris Pharmaceuticals Group Co., Ltd.
7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Job Adjustment', 'Redundancy', 'Retirement', 'Death', or 'New Appointment'): Term Expiration
8. Reason for Change: Re-election due to term expiration
9. Effective Date of New Appointment: 115/05/15
10. Other Matters Requiring Notification (If the subject of the event or resolution is a publicly issued company or above, this major information also complies with Article 7, Clause 6 of the Enforcement Rules of the Securities Transaction Act regarding matters that have a significant impact on shareholder equity or stock prices): None
FAQ
What is the company code for Polaris Pharmaceuticals-KY?
The company code is 6550.
Who was elected as the new Chairman?
Chen Xian-Zhe was re-elected as Chairman.
What was the reason for the change in chairmanship?
The reason was the expiration of the term and subsequent re-election.
When did the board meeting take place?
The board meeting took place on May 15, 2026.